Zq. Ma et al., ESTROGENIC CONTROL OF MONOAMINE-OXIDASE-A ACTIVITY IN HUMAN NEUROBLASTOMA-CELLS EXPRESSING PHYSIOLOGICAL CONCENTRATIONS OF ESTROGEN-RECEPTOR, European journal of pharmacology, 284(1-2), 1995, pp. 171-176
Several lines of evidence support the hypothesis of a role played by e
strogens in the manifestation of affective disorders in women. The ana
lysis of the mechanism of action of a number of antidepressant drugs c
learly demonstrated the involvement of the catecholaminergic system in
the etiology of these complex behavioral pathologies. The present in
vitro study was therefore undertaken to investigate the presence of a
functional link between estrogen and catecholamine metabolism in cells
of neural origin. The model system utilized was a human neuroblastoma
cell line which was obtained by stable transfection of the estrogen r
eceptor cDNA (SK-ER3). The present study shows that in SK-ER3 activati
on of the estrogen receptor correlates with a marked decrease in monoa
mine oxidase A activity. This effect is observed following treatment w
ith a physiological concentration of 17 beta-estradiol and can be bloc
ked by the specific antagonist of the steroid receptor, ICI 182,780. D
ibutyryl cyclic AMP acting, like estrogens, on the state of differenti
ation of SK-ER3 cells did not affect monoamine oxidase A activity. The
present study provides strong evidence of a strict relationship betwe
en estrogen receptor and monoamine oxidase A activity in human cells o
f neural origin, thus favoring the hypothesis of an antidepressive eff
ect of estrogens exerted via inhibition of the monoamine oxidative pat
hway.